all report title image
  • Published On : Jan 2020
  • Code : CMI23
  • Industry : Biotechnology
  • Pages : 110
  • Formats :
Ingographics Image

Dengue fever is a mosquito-borne viral infection causing a severe flu-like illness. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Dengue is most likely to affect individual’s tropical and subtropical countries. Increasing prevalence of dengue is expected to propel growth of the global dengue vaccine market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global Dengue Vaccine and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Dengue Vaccine based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Dengue Vaccine report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Dengue Vaccine Market, By End User:
    • Hospitals
    • Government Institutes
    • NGOs
  • Dengue Vaccine Market, By Region:
    • Latin America
      • By End User
        • Hospitals
        • Government Institutes
        • NGOs
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Asia Pacific
      • By End User
        • Hospitals
        • Government Institutes
        • NGOs
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By End User
        • Hospitals
        • Government Institutes
        • NGOs
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By End User
        • Hospitals
        • Government Institutes
        • NGOs
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
    • Rest of World
      • By End User
        • Hospitals
        • Government Institutes
        • NGOs
  • Company Profiles
    • Sanofi *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Takeda Pharmaceutical Company Limited
    • GlaxoSmithKline
    • Merck & Co.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Product Approval
    • Regulatory Scenario
  4. Global Dengue Vaccine Market, By End User 2019– 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Government Institutes
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • NGOs
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  5. Global Dengue Vaccine Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • Latin America
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Asia Pacific
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
    • Rest of World
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, 2016 – 2027, (US$ Mn)
  6. Competitive Landscape
    • Company Profiles
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Takeda Pharmaceutical Company Limited
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GlaxoSmithKline
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck & Co.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 14 market data tables and 10 figures on “Dengue Vaccine – Global forecast to 2027.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo